Diagnostics and research stocks with the lowest EV/EBIT
What the whole business costs (market value plus debt, less cash) against operating profit over the last twelve months, one-off items taken out. As of .
- Ranked
- 25
- of 74 diagnostics and research stocks we cover
- Median
- 30.9×
- Lowest
- 0.1×
- ADVB
- Range
- 0.1× to 128×
median 30.9×
0.1×128×
| # | Company | EV/EBIT | PE | Operating margin | Market cap |
|---|---|---|---|---|---|
| 1 | ADVBAdvanced Biomed | 0.1× | n/m | n/m | $3.4M |
| 2 | ICCCImmucell | 14.6× | 132× | 12.6% | $95.9M |
| 3 | DGXQuest Diagnostics | 19.0× | 24.9× | 14.6% | $27.5B |
| 4 | LNTHLantheus | 20.8× | 24.3× | 19.4% | $6.5B |
| 5 | BRKRBruker | 22.5× | n/m | −0.9% | $8.5B |
| 6 | LHLabcorp | 22.9× | 29.4× | 10.4% | $28.9B |
| 7 | IQVIQVIA | 25.4× | 32.0× | 13.0% | $42.5B |
| 8 | CRLCharles River Laboratories International | 25.6× | n/m | 2.3% | $16.2B |
| 9 | VCYTVeracyte | 27.9× | 35.0× | 18.8% | $3.9B |
| 10 | AVTRAvantor | 28.2× | n/m | −4.6% | $10.6B |
| 11 | MEDPMedpace | 30.4× | 38.0× | 21.0% | $18.1B |
| 12 | MTDMettler-Toledo International | 30.6× | 38.4× | 27.8% | $34.2B |
| 13 | AAgilent Technologies | 30.9× | 34.5× | 22.2% | $49.6B |
| 14 | TMOThermo Fisher Scientific | 33.3× | 36.7× | 17.9% | $256.9B |
| 15 | DHRDanaher | 34.2× | 37.9× | 20.4% | $162.6B |
| 16 | IDXXIDEXX Laboratories | 36.3× | 46.5× | 32.0% | $52.1B |
| 17 | ILMNIllumina | 36.6× | 44.0× | 19.6% | $35.7B |
| 18 | CDNACareDx | 37.7× | 35.9× | 23.4% | $4.5B |
| 19 | BIOBio-Rad Laboratories | 39.7× | 44.4× | 2.1% | $9.8B |
| 20 | NRCNRC Health | 42.3× | 97.0× | 10.5% | $536.6M |
| 21 | RVTYRevvity | 44.2× | 72.2× | 12.3% | $16.9B |
| 22 | CAICaris Life Sciences | 56.6× | 86.8× | 15.5% | $9.1B |
| 23 | RDNTRadNet | 74.5× | n/m | 3.1% | $5.8B |
| 24 | BLLNBillionToOne | 110× | 170× | 10.9% | $5.2B |
| 25 | WATWaters | 128× | 118× | 7.1% | $46.4B |
Not ranked: 44 with a loss over the last year, 3 with not a meaningful number. 2 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
EV/EBIT for other groups
Other rankings of diagnostics and research stocks
- Diagnostics and research stocks with the lowest PE ratio
- Diagnostics and research stocks cheapest against their own PE history
- Diagnostics and research stocks with the lowest price to sales ratio
- Diagnostics and research stocks with the highest free cash flow yield
- Diagnostics and research stocks with the fastest revenue growth
- Diagnostics and research stocks with the fastest expected revenue growth
- Diagnostics and research stocks with the fastest earnings growth
- Diagnostics and research stocks with the highest profit margins